-+ 0.00%
-+ 0.00%
-+ 0.00%

ADAPTIVE BIOTECHNOLOGIES ANNOUNCES UPDATE TO NCCN GUIDELINES® FOR MULTIPLE MYELOMA, STRENGTHENING MRD TESTING RECOMMENDATIONS AND SPECIFICALLY REFERENCING CLONOSEQ®

Reuters·09/17/2026 12:00:04

Please log in to view news